Renal Cell Carcinoma (Kidney Cancer) Support Group

CyberKnife Benefits Patients with Difficult Tumors

Patients with tumors along the spinal cord or in other critical locations can now benefit from state-of-the-art treatment that directs high-dose radiation at the tumor while preserving healthy tissues.

A noninvasive procedure, it is the latest development in stereotactic radiosurgery technology and goes by the name CyberKnife. UCSF Medical Center is one of only 12 health care institutions in the country offering this treatment to patients.




--------------------------------------------------------------------------------



Print story


E-mail story



--------------------------------------------------------------------------------


With the addition of CyberKnife, UCSF physicians have every weapon in the modern arsenal to fight tumors in hard-to-treat areas, according to William Wara, MD, professor and chair of the UCSF Department of Radiation Oncology.

He said the precision targeting of this device offers a significant improvement for some patients with tumors of the lung, pancreas, head or neck, as well as those with spine and brain tumors, both benign and malignant.
Posted on 02/14/07, 11:02 pm